The concentration of intracerebral glucose as a function of plasma glucose concentration was measured in rats by 13e NMR spectroscopy. Measurements were made in 20-60 min periods during the infusion of [1_13C]O glucose, when intracerebral and plasma glucose levels were at steady state. Intracerebral glucose was found to vary from 0.7 to 19 ILmol g-I wet weight as the steady state plasma glucose concentration was varied from 3 to 62 mM. A symmetric Michaelis-Menten model was fit to the brain and plasma glucose data with and without an unsaturable component, yielding the transport parame ters Km, V max' and Kd• If it is assumed that all transport is saturable (Kd = 0), then Km = 13. 9 ± 2.7 mM and emission tomography.
Under normal physiological conditions, glucose is the major source of energy for the brain (Him wich and Nahum, 1929; Siesjo, 1978) . Glucose transport across the blood-brain barrier has been reported to be primarily a saturable process of fa cilitated diffusion (Crone, 1965) . Reported values of the maximum rate of influx (V m a x) for glucose trans port in rat brain range from 0.53 to 6.7 j.Lmol min-1 g-l (Gjedde and Diemer, 1985) . Most reported values of V m a x are larger than the basal rate of glucose utilization (0.62-1.1 j.Lmol min-1 g-I) (Hawkins et al., 1974; Sokoloff et al., 1977; Fitzpatrick et al., 1990) , indicating that trans port is not rate limiting in these conditions. How ever, in some conditions, glucose transport may limit glucose utilization due to increased glucose consumption as in seizures (Kennedy et al., 1975; Borgstrom et al., 1976) or due to decreased trans porter density as reported in chronic hyperglycemia (Gjedde and Crone, 1981; McCall et al., 1982) and Alzheimer disease (Kalaria and Harik, 1989; Jagust et al., 1991) .
A variety of methods have been used to study brain glucose transport. Chemical methods for de termining glucose require fixation of the brain prior to its removal, and are therefore sensitive to post mortem metabolism (see Table 2 ). Autoradio graphic methods using nonmetabolizable glucose analogues such as e4C]deoxyglucose (Sokoloff et al., 1977) or e4C]glucose (Gaitonde, 1965; Hawkins et al., 1979) yield regional information about glu cose utilization. These methods, however, require brain removal and corrections for differences in transport kinetics between glucose and the labeled analogues and/or assumptions about the labeling of products beyond glucose.
Radioisotope methods in conjunction with posi tron emission tomographic (PET) techniques with compounds like [18F]tluorodeoxyglucose, [llC]deoxy glucose (Reivich et al., 1979 (Reivich et al., , 1985 Phelps et al., 1979) , and [llC]glucose (Raichle et aI., 1975; Sacks et aI., 1982; Blomqvist et aI., 1990; Gutniak et aI., 1990) have allowed noninvasive regional assess ment of glucose transport. An alternative method of studying glucose transport is l3C nuclear magnetic resonance (NMR) . In contrast with previous meth ods, 13C NMR is both noninvasive and allows the direct detection of intracerebral glucose following the infusion of 13C-Iabeled glucose (Behar et aI., 1986) . We report here the development of an NMR method for measuring brain glucose concentrations in vivo. A Michaelis-Menten model of facilitated transport was used to determine the kinetic param eters Km and V max from the NMR data. An exten sion of the model to include an un saturable compo nent Kd was investigated. A comparison of the NMR results to those obtained by a variety of other methods has been made. Preliminary results of this study were presented in an abstract (Mason et aI., 1990) .
MATERIALS AND METHODS

Animal preparation
Male Sprague-Dawley rats weighing 170-240 g and fasted 20-30 h were anesthetized with 2.0% enflurane, tracheotomized, and ventilated with a mixture of 30% 0 2 170% N 2 0. The tail artery was cannulated in order to monitor blood pressure and to obtain blood for measure ment of pH, pC0 2 , and p0 2 ' The mean arterial blood pressure was maintained above 90 mm Hg for all animals, after correction for the hydrostatic head caused by the elevation and vertical orientation of the animal in the magnet. A tail vein was also cannulated for infusion of 13C-Iabeled glucose according to a previous procedure (Fitzpatrick et aI., 1990) . The scalp was retracted and a single-turn elliptical surface coil (8 x 12 mm) placed on the skull.
In experiments at hyperglycemic glucose levels, the plasma glucose concentration and the l3C fractional en richment was raised and maintained at constant levels during the NMR measurement by infusion of a solution of [l-\3C]glucose (99 atom %; Merck, Rahway, NJ, U.S.A.), according to the protocol described by Fitzpatrick et al. (1990) . For NMR measurements with plasma glucose at or below 20 mM, the concentration of the solution was 0.75 M per 200 g of body weight and adjusted proportion ally to the weight of each animal. To reach higher plasma glucose concentrations, the infusate was a solution of 50% glucose (weight/volume) with a 50% [l-13C]glucose enrichment in distilled water.
To achieve high 13C fractional enrichments in the seven measurements made at lower plasma glucose concentra tions, the endogenous plasma glucose concentration was first reduced to 3.5-4 mM in 15-30 min by injection of insulin (100 U/kg i.p.) prior to the infusion of [l-13C]glu cose. Immediately thereafter, [l-13C]glucose was infused for 9 min, raising the plasma glucose concentration and 13C fractional enrichment. The plasma glucose concentra tion was then allowed to drop to the desired concentra tion, and the [1-\3C]glucose infusion was restarted at a rate adequate to maintain constant values of plasma glu cose concentration and 13C fractional enrichment during the measurement.
The premortem glucose signal intensity was quanti tated relative to postmortem lactate following a cardiople gic dose of potassium chloride. The concentration of [3-13C]lactate was determined by IH NMR (see below).
Extracts
Following postmortem NMR measurements, the brain was removed and a small portion of the temporal/parietal cortex was weighed and frozen in liquid N 2 . Brain tissue was extracted with 3 M perchloric acid (1:2.75 weight/ volume) at -20°C according to Behar et al. (1986) . Fol lowing centrifugation, the supernatants were neutralized with 10 N KOH, recentrifugated, the supernatant lyo philized, and the powder resuspended in 500 J-ll of D 2 0 for analysis by IH NMR.
Plasma samples (30-100 J-ll) were extracted in 0.3 M perchloric acid (3: 1 volume/volume). Following centrifu gation, the supernatants were neutralized with 3.0 M KOH. The supernatant was lyophilized, dissolved in 150 ILl of D 2 0, and placed in microcell tubes for analysis by IH NMR.
In vivo and postmortem analysis l3C NMR spectra were obtained with a surface coil double-tuned either to the IH and 13C frequencies or the IH and 31p frequencies (den Hollander et aI., 1984) , using an AM360 wide-bore spectrometer with an 8.4 T field (Bruker Instruments, Karlsrue, Germany). Field homo geneity was optimized by shimming with the water resonance, yielding full widths at half-height of 22-28 Hz. Metabolite signals were obtained mainly from the cere bral cortex (Fitzpatrick et aI., 1989 ). l3C NMR with 1 H-decoupling. \3C NMR spectra were obtained at 90.55 MHz with WALTZ-16 IH-decoupling at 2.2 W during the 0.3 s acquisition. Broad-band decoupling at 0.26 W was delivered prior to acquisition to develop a nuclear Overhauser enhancement (NOE). The repetition time was 0.5 s. During detection of [1-l3C]glucose, the IH-decoupling was centered on water at 4.7 ppm, and during detection of [3-l3C]lactate, the IH-decoupling was centered on the lactate methyl protons at 1.33 ppm.
Proton-observed, l3C-edited (POCE) NMR. [3-13C]
Lactate and total creatine were observed in the IH NMR spectrum at 360.13 MHz using the POCE sequence (Roth man et aI., 1985; Fitzpatrick et aI., 1990) under fully re laxed conditions. For lactate detection in the IH spec trum, the semiselective pulse excitation maximum was placed on the lactate methyl IH resonance at 1.33 ppm. The l3C resonance of carbon C3 of lactate was inverted on alternate scans with a composite pulse (13C) applied to the lactate methyl 13C resonance at 21 ppm; composite pulse 13C-decoupling centered at 21 ppm was used during lactate acquisitions in the IH spectrum. For creatine de tection, the IH NMR semiselective pulse optimum was placed on the creatine methyl protons (3.03 ppm), and the l3C inversion pulse and decoupling were applied 150 kHz off resonance. In the absence of l3C decoupling, the sig nal at 3.0 ppm arises primarily from total creatine (cre atine + phosphocreatine) and unlabeled -y-aminobutyric acid (GABA) (Behar et aI., 1983) . 31p NMR. 31p NMR spectra were acquired at 145.78
MHz using a 0.6 s repetition time. The intracellular pH (pHi) was determined from the chemical shift difference of inorganic phosphate (PJ and phosphocreatine (PCr) using the titration curve of Petroff et al. (1985) .
NMR of brain extracts. Fully relaxed IH spectra of brain extracts were obtained using a pulse angle of 90° and a repetition time of 20 s. Creatine (3.03 ppm) and GABA (3.02 ppm) were observed without 13C decoupling. Chemical shifts were referenced to the resonance of so dium 3-trimethylsilyl-propionate-2,2,3, 3-d4 (TSP) (Merck) at 0.00 ppm.
NMR of plasma extracts. IH spectra of plasma extracts were obtained as previously described (Behar et al., 1986) at a temperature of 47"C in order to determine the 13C fractional enrichment of the (X anomer of the C 1 proton resonance ofD-glucose. The residual HDO peak was sup pressed by presaturation. Due to the low concentration of glucose and the small sample size, spectra were obtained under saturating conditions (repetition time of 3.16 s). The intensity of the unlabeled Cl IH NMR signal was multiplied by a measured factor (1.67 ± 0.11) to correct for the difference in the relaxation rates of the Cl proton of [l_13C]-and [l-1 2 C]glucose.
Quantitation of intracerebral glucose by NMR spectroscopy
The integrated signals of the (X and 13 anomers of [1-13C]glucose were averaged over periods during which the brain glucose 13C NMR signal was stable and the plasma glucose concentration varied within ± 15%. Since no internal concentration reference exists in the 13C NMR spectrum and it was not possible to include an external standard due to the size restrictions of the vertical bore spectrometer, it was necessary to use the [3-13C]lactate generated after death to quantitate premortem glucose levels (Fig. 1) . The 13C NMR signal of [3-13C]lactate was acquired for 40 min after stabilization of the signal inten sity. The concentration of [l-13C]glucose relative to that of [3-13C]lactate was determined by comparing the inte grated 13C NMR resonance intensity of lactate with the average intensity of the (X and 13 anomers of glucose and correcting for differences in saturation and NOE devel opment between lactate and glucose. The concentration of creatine was assumed to be 10.5 J.1mol g -I of wet weight (Lewis et al., 1974b) .1 Since GABA and creatine are not resolved in IH NMR spectra obtained in situ, the contribution of GABA to the total resonance intensity at 3 ppm was determined from analysis of the high resolution IH NMR acid extract spectra. All resonance intensities were measured manually using a compensating planimeter.
The total glucose concentration in the brain (Gj) was calculated by dividing the 13C glucose concentration by the [1-13C]fractional enrichment of the plasma glucose av eraged over the period of the NMR measurement. The 13C NMR signal was corrected for contributions from blood glucose by assuming a vascular volume of 3% (Bus chiazzo et al., 1970) . Uncertainties for individual glucose measurements were calculated from the signal-to-noise ratios of the NMR spectra at each quantitation step. Like 1 The concentration of total creatine (creatine + phosphocre atine) has been measured during and after complete ischemia (Ljunggren et aI., 1974) , as well as under a wide range of other physiological conditions, and no significant differences have been found (Ponten et aI., 1973; Bachelard et aI. , 1974; Lewis et aI., 1974b; MacMillan, 1975; Agardh et aI., 1978; Pelligrino and Siesj6, 1981) . most other brain glucose measurements, this one yields values per gram of tissue without distinguishing between intra-and extracellular glucose. However, for the kinetic analyses of transport described below, it was assumed that the glucose concentration is equal throughout the distribution space. 
THEORY
Modeling of transport
The brain and plasma glucose concentrations were analyzed to determine transport kinetics using two models, both of which assume uniform distri bution of glucose throughout the brain water space when a steady-state brain glucose concentration is reached. The first treats glucose transport as a paired set of Michaelis-Menten enzymes: one for glucose influx and one for glucose efflux. This sym metric Michaelis-Menten model at steady state is described by the following equation (Siesj6, 1978; Lund-Andersen, 1979) :
where Km is the half-saturation concentration for transport, V max is the maximum transport rate, and V g 1 y is the rate of cerebral glucose consumption, assumed in the analysis to be independent of Go and Gi.
In the second model, an unsaturable transport component (Kd) was included (Pard ridge and Old endorf, 1977), changing Eq. (1) to (2) =0 Kd represents either facilitated transport with neg ligible saturability or non-carrier-mediated diffusion of glucose across the blood-brain barrier.
Computational methods
In order to derive glucose transport kinetics, Eqs.
(1) and (2) were fit to the steady-state cerebral glu cose concentration data (Gjedde and Christensen, 1984) using nonlinear least-squares analysis, by means of a modified simplex algorithm provided by Dr. H. P. Hetherington that uses a least-squares fit as the target function, adapted for iteration with Km, V m a xlV g l y , and KdlV g 1 y ' The calculation was performed on a Dell 486 33 MHz (433E) personal computer (Austin, TX, U.S.A.) with software writ ten using Turbo Pascal 3.0 (Borland International, Inc., Scotts Valley, CA, U.S.A.).
Uncertainties in the values of Km, V m a xlV g l y , and KdlV g l y were determined from the scatter of the data about the least-squares fit by a method similar to that of Kuwabara et al. (1990) . The standard devi ation of the scatter (a�oise) was determined accord ing to the equations a �ois e = x 2 /( n -1) n 2"" '2 X = LJ (Gij -Gij) j= l
( 3) where Gij is the concentration of brain glucose mea sured at the plasma glucose concentration Go}' and measurements were made at Gol' Go2' ... , Gon'
and Gij = the concentration of brain glucose pre dicted by the model at G O }' The noise power was assumed to be random with a Gaussian distribution of width defined by a�oise as determined in Eq.
(3). Sets of brain glucose concentrations (Gij) and plasma glucose concentrations ( G o ) were simulated by adding randomly generated noise having the same Gaussian distribution (a�oise) to the calculated fit of the model. A least-squares fit to the artificial data sets was determined, and the calculated values of Km, V ma)V g 1 y , and KdlV g l y were recorded. This procedure was repeated 70--150 times, and from the range of values of each parameter the variances ak , at IV , and ak IV were calculated. The comm max gly d gly putation was ended when the variances of all iterated values changed by less than 0.8% in five con secutive repetitions.
RESULTS
Physiology
The blood pH, pC02, and p0 2 measured for all experiments are given in Table 1 . No significant differences were observed between insulinized and uninsulinized rats, and no significant affect of plasma glucose concentration was observed. 3lp spectra revealed no alterations in 31p metabolite levels (nucleotide triphosphate, phosphocreatine, and inorganic phosphate) or intracellular pH during the infusion of [l-l3C]glucose, compared to the nor mal energy state (Behar et aI., 1985) .
Intracerebral glucose concentration
Following an intravenous infusion of [1-l3C]glu cose, the Cl of the ex and 13 anomers of glucose was detected in the l3C NMR spectrum of the rat brain ( Fig. O. As shown in Fig. 2 , brain glucose was quantitated over time periods when brain and plasma levels were stable. A plot of the measured brain glucose concentration as a function of the plasma glucose concentration for each measure ment is shown in Fig. 3 . Measurements were made at plasma glucose levels between 3.1 and 62 mM. The brain glucose varied from 0.7 to 19 f,Lmol g-l.
The ratios of brain to plasma glucose calculated for the entire data set varied from �0.2 to �0.45 ml g-l.
A symmetric Michaelis-Menten model of glucose transport [Eq. (1)] was fit to the data as shown in Fig. 3 . The best fit was obtained with values of 13.9 ± 2.7 mM for Km and 5.8 ± 0.8 for V maxlV g l y ' The symmetric Michaelis-Menten model modified to in clude an unsaturable component yielded values of 9.2 ± 4.7 mM for Km, 5.3 ± 1.5 for V maxlV g l y , and 0.0088 ± 0.0075 ml f,Lmol-1 for KdlV g 1 y ' Inclusion of this term resulted in a reduction of 33.8% in Km, but only 8.6% in V max' compared to the case of Kd = O.
DISCUSSION
Brain glucose concentration
The level of intracerebral glucose determined by NMR was less than the plasma glucose level, with a brain-to-plasma glucose concentration ratio of �0.2 to �0.45 ml g-I. Table 2 is a compilation of glucose concentration measurements obtained in rat brain using various techniques. The ratios of brain-to plasma glucose calculated from the present data are in closest agreement with values obtained using fo cused microwave irradiation and freezing in situ, methods that arrest glucose metabolism quickly.
J Cereb Blood Flow Metab, Vol. 12, No.3, 1992 Based on the signal-to-noise ratio of the NMR spectra at each step of quantitation, the measure ments are sensitive to within 10-20% of the glucose concentration. Sensitivity could be improved by us ing external standards, which are feasible in hori zontal magnets with wider bores and have been used with humans (Gruetter et aI., 1991) .
Determination of V max and Kd
Values of V max and Kd were determined from the calculated ratios of V maxlV g l y and KdlV g 1 y , using the glucose utilization rate of 0.8 f,Lmol min -I g of wet weight 1 reported by Fitzpatrick et al. (1990) for an imals studied under conditions similar to the present study. Using the saturable Michaelis Menten model, V max was calculated to be 4.6 ± 0.6 f,Lmol min -1 g -I. With an un saturable component included in the model, values of 4.2 ± 1.2 f,Lmol min-I g-I and 0.007 ± 0.006 ml min-I g-I were determined for V max and Kd, respectively.
Given a unidirectional uptake rate (Vin) of Go V max i (Km + Go), the value of Yin in euglycemia (Go = 10 mM) is 2.4 ± 0.4 times greater than the glucose utilization rate, indicating that glucose transport is not a controlling step for glucose utilization under normal conditions. The values determined for V max and Kd are higher than values reported in non steady-state measurements (Table 3) , which may be artifactually low (Lund-Andersen, 1979) . The value of Km, assuming saturable transport, as calculated a Measurements with pentobarbital anesthetic. b The plasma glucose concentration was not reported. Since the animals were given free access to food and water, the plasma glucose concentra tion was probably -9 mM. C Calculated by Gjedde and Christensen (1984) . Values are for frontal or parietal cortex when available and for whole brain when not. Dashes for K d mean that the parameter was not evaluated.
" Measured using sodium pentobarbital anesthesia. b K rn is an average of values from other investigators by Lund-Andersen (1979) .
C Gjedde and Christensen (1984) calculated VrnaxiV,ly to be 3.7. For V"y = 0.8 �mol min-1 g-1 (Fitzpatrick et aI., 1990) , Vmax = 3.0 �mol min -1 g-l .
d Measured using halothane anesthesia.
from the present NMR data (13.9 mM) is higher than previously reported values. The fractional un certainty in Km is considerably larger than that of V max' Also in contrast to V max' the value of Km is very sensitive to the value of Kd. The sensitivity exists because Kd is functionally equivalent to a separate transporter with an extremely high value of Km; any apparent linear dependence of the data can be absorbed by Kd, lowering the estimate of Km. When Kd is included, the value of Km derived from the NMR data is 9.2 mM, which is within the range of previous studies, many of which included Kd in their analyses. An upper limit of K d was cal culated to be 0.013 ml min -I g-I, based on the range of uncertainty determined from the scatter analysis (0.007 ± 0.006 ml min-I g-I).
We have shown that 13C NMR can be used for direct detection of the intracerebral glucose concen tration in the rat brain. In this study, quantitation of intracerebral glucose levels in vivo was based on the postmortem measurement of [3-13C]lactate. However, large bore magnets in conjunction with external concentration standards will allow the pro cedure to be performed entirely in vivo, as recently demonstrated for the human brain by Gruetter et al. (1992) . Extension of this method to localized spec troscopy (Ordridge et al., 1986; Hanstock et al., 1988 ) should permit regional determinations of glu cose transport parameters in a host of human cere bral disorders involving suspected changes in glu cose metabolism and/or transport, such as diabetes and Alzheimer disease.
